Michael G. Rolf

711 total citations
13 papers, 439 citations indexed

About

Michael G. Rolf is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Michael G. Rolf has authored 13 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 5 papers in Physiology and 4 papers in Molecular Biology. Recurrent topics in Michael G. Rolf's work include Adenosine and Purinergic Signaling (5 papers), Receptor Mechanisms and Signaling (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Michael G. Rolf is often cited by papers focused on Adenosine and Purinergic Signaling (5 papers), Receptor Mechanisms and Signaling (3 papers) and Cardiac electrophysiology and arrhythmias (3 papers). Michael G. Rolf collaborates with scholars based in United Kingdom, Sweden and Switzerland. Michael G. Rolf's co-authors include Martyn P. Mahaut‐Smith, Richard J. Evans, Charles A. Brearley, Steven J. Ennion, Catherine Vial, Martin Braddock, Jon Curwen, Cath Eberlein, Margaret H. Veldman-Jones and Samantha J. Pitt and has published in prestigious journals such as Blood, British Journal of Pharmacology and Drug Discovery Today.

In The Last Decade

Michael G. Rolf

11 papers receiving 430 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael G. Rolf United Kingdom	7	225	176	142	110	53	13	439
Martin Tschöpl Switzerland	10	128 0.6×	96 0.5×	27 0.2×	123 1.1×	28 0.5×	12	428
Jean Philippe Breittmayer France	15	174 0.8×	84 0.5×	16 0.1×	228 2.1×	54 1.0×	26	518
Sarah Sargin Germany	8	178 0.8×	26 0.1×	13 0.1×	182 1.7×	135 2.5×	11	459
John E. Cuffe United Kingdom	8	61 0.3×	32 0.2×	33 0.2×	278 2.5×	11 0.2×	8	410
Jutta Lindenborn-Fotinos Germany	7	315 1.4×	46 0.3×	8 0.1×	293 2.7×	53 1.0×	8	814
Josée‐Martine Durand‐Gorde France	15	80 0.4×	30 0.2×	20 0.1×	166 1.5×	184 3.5×	23	554
Stéphanie Chadet France	10	154 0.7×	40 0.2×	5 0.0×	154 1.4×	52 1.0×	24	332
Sandra M. Soares United States	7	274 1.2×	17 0.1×	25 0.2×	176 1.6×	31 0.6×	8	578
Nicola J. Weston-Bell United Kingdom	10	10 0.0×	41 0.2×	24 0.2×	123 1.1×	53 1.0×	19	359
Arthur Kmit Portugal	10	42 0.2×	27 0.2×	10 0.1×	203 1.8×	44 0.8×	13	436

Countries citing papers authored by Michael G. Rolf

Since Specialization

Citations

This map shows the geographic impact of Michael G. Rolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael G. Rolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael G. Rolf more than expected).

Fields of papers citing papers by Michael G. Rolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael G. Rolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael G. Rolf. The network helps show where Michael G. Rolf may publish in the future.

Co-authorship network of co-authors of Michael G. Rolf

This figure shows the co-authorship network connecting the top 25 collaborators of Michael G. Rolf. A scholar is included among the top collaborators of Michael G. Rolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael G. Rolf. Michael G. Rolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Sillito, Rowland R., Justin Sutherland, Chiara Giuliano, et al.. (2025). Rodent home cage monitoring for preclinical safety pharmacology assessment: results of a multi-company validation evaluating nonclinical and clinical data from three compounds. Frontiers in Toxicology. 7. 1655330–1655330.

Morris, Christopher J., Michael G. Rolf, Linda M. Starnes, et al.. (2024). Modelling hemodynamics regulation in rats and dogs to facilitate drugs safety risk assessment. Frontiers in Pharmacology. 15. 1402462–1402462.

Harmer, Alexander R. & Michael G. Rolf. (2024). On the relationship between hERG inhibition and the magnitude of QTc prolongation: An in vitro to clinical translational analysis. Toxicology and Applied Pharmacology. 492. 117135–117135. 1 indexed citations

Vogel, Florian, Christos Andronis, Thomas Seidel, et al.. (2023). GABAA receptor-mediated seizure liabilities: a mixed-methods screening approach. Cell Biology and Toxicology. 39(6). 2793–2819. 3 indexed citations

Rossman, Eric I., Todd Wisialowski, Hugo M. Vargas, et al.. (2023). Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As. Journal of Pharmacological and Toxicological Methods. 123. 107270–107270. 12 indexed citations

Rolf, Michael G., et al.. (2020). Current and future approaches to nonclinical cardiovascular safety assessment. Drug Discovery Today. 25(7). 1129–1134. 4 indexed citations

Hall, Anthony, et al.. (2016). Femoral Head Growth Plate Dysplasia and Fracture in Juvenile Rabbits Induced by Off-target Antiangiogenic Treatment. Toxicologic Pathology. 44(6). 866–873. 2 indexed citations

Rolf, Michael G., et al.. (2015). In vitro pharmacological profiling of R406 identifies molecular targets underlying the clinical effects of fostamatinib. Pharmacology Research & Perspectives. 3(5). e00175–e00175. 67 indexed citations

Vial, Catherine, et al.. (2003). Lack of evidence for functional ADP-activated human P2X1 receptors supports a role for ATP during hemostasis and thrombosis. Blood. 102(10). 3646–3651. 26 indexed citations

10.

Vial, Catherine, Michael G. Rolf, Martyn P. Mahaut‐Smith, & Richard J. Evans. (2002). A study of P2X₁ receptor function in murine megakaryocytes and human platelets reveals synergy with P2Y receptors. British Journal of Pharmacology. 135(2). 363–372. 66 indexed citations

11.

Rolf, Michael G. & Martyn P. Mahaut‐Smith. (2002). Effects of Enhanced P2X1 Receptor Ca2+ Influx on Functional Responses in Human Platelets. Thrombosis and Haemostasis. 88(9). 495–502. 32 indexed citations

12.

Rolf, Michael G., Charles A. Brearley, & Martyn P. Mahaut‐Smith. (2001). Platelet Shape Change Evoked by Selective Activation of P2X1 Purinoceptors with α,β-Methylene ATP. Thrombosis and Haemostasis. 85(2). 303–308. 112 indexed citations

13.

Mahaut‐Smith, Martyn P., Steven J. Ennion, Michael G. Rolf, & Richard J. Evans. (2000). ADP is not an agonist at P2X₁ receptors: evidence for separate receptors stimulated by ATP and ADP on human platelets. British Journal of Pharmacology. 131(1). 108–114. 114 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact